Target intelligence / Profile preview

Alcohol dehydrogenase enzyme (ADH)

Target
ADH
Molecular classification
Enzyme, Oxidoreductase, Zinc metalloenzyme
01

Overview

Alcohol dehydrogenase enzyme (ADH) is a family of zinc-dependent oxidoreductase enzymes that catalyze the reversible oxidation of alcohols to aldehydes or ketones using NAD+ as a cofactor[2][3][4][6]. In humans, multiple ADH isoforms (ADH1-ADH7) are expressed, with liver isoforms playing a major role in the detoxification and metabolism of ethanol and other alcohols. ADH enzymes are crucial for physiologically removing toxic alcohols and for generating metabolic intermediates, such as acetaldehyde from ethanol. They are involved in retinol metabolism, neurotransmitter biosynthesis, and many other metabolic pathways. Genetic variants in ADH genes affect the rate of ethanol metabolism and are implicated in disease susceptibility, intoxication risk, and adverse drug reactions[2][3][4]. Drugs such as fomepizole and disulfiram interact with ADH, modulating its activity in clinical treatment of alcohol intoxication and dependence[2][4]. Dysfunction or altered activity of ADH is associated with risk for alcoholism, alcohol-induced organ damage, cancer, and other diseases[3][4].

Other names
Alcohol dehydrogenaseADHethanol dehydrogenasealcohol:NAD+ oxidoreductase
02

Mechanism of action

Substrate competition (e.g., ethanol inhibits methanol oxidation via competitive inhibition); Inhibition of enzyme activity (e.g., fomepizole directly inhibits ADH, decreasing metabolism of toxic alcohols); Impaired enzyme function by genetic polymorphisms; Enzyme inhibition (e.g., disulfiram blocks aldehyde dehydrogenase, but also has minor effects on ADH)

03

Biological functions

Oxidation of alcohols to aldehydes or ketonesDetoxification of alcoholsMetabolism of ethanolRetinoid (vitamin A) metabolismMetabolism of biogenic amines (in some isoforms)
04

Disease associations

Alcohol use disorderAlcohol intoleranceCancerCardiovascular diseaseNeurodegenerative diseaseFetal alcohol spectrum disordersLiver disease
05

Safety considerations

Accumulation of toxic acetaldehyde in slow metabolizers or under ADH inhibitionDisulfiram-ethanol reaction (flushing, nausea, cardiovascular complications)Drug-ethanol interactions
06

Interacting drugs

Ethanol

4 more in the full profile.

07

Biomarkers

Enzyme activity levels (ADH isoforms) in blood or liverGenetic polymorphisms (e.g., ADH1B, ADH1C variants)Blood or breath ethanol and acetaldehyde levels

Beyond the preview

Go deeper on Alcohol dehydrogenase enzyme (ADH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alcohol dehydrogenase enzyme (ADH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call